Percutaneous treatment in acute coronary syndromes
نویسندگان
چکیده
منابع مشابه
Prognostic value of C-Reactive Protein in Acute Coronary Syndromes
Introduction: Coronary artery disease (CAD) is among the most common, serious, chronic and life- threatening illnesses in the world. CAD represents a spectrum of conditions, with acute myocardial infarction at one end of it and silent ischemia at the other. There is growing evidence on importance of prognosis of C- reactive protein (CPR) in unstable angina and this protein is a maker of an adve...
متن کاملAcute coronary syndromes - pharmacological treatment
The term acute coronary syndrome (ACS) describes the spectrum of disease from acute myocardial infarction (MI) to unstable angina, as described in the first article of this feature (p285).The primary cause of these diseases is essentially the same — thrombosis of a coronary artery leading to ischaemia and possibly infarction of the myocardium.The degree of ischaemia or infarct size is related t...
متن کاملAntiplatelet treatment in acute coronary syndromes
Platelets play a major role in the development of acute coronary syndromes (ACS) and thromboembolic complications during and after percutaneous coronary interventions (PCI). Because of the widespread usage of platelet inhibitor agents in the treatment of patients with a broad spectrum of ACS it appears to be important to review the data concerning the usefulness and limitations of these agents....
متن کاملDynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention
Background: Cardiovascular diseases are global problems. They are causes of death in about 43% of people worldwide and may become the most widespread reason of death by 2020. The prognosis is directly dependent to immediate diagnosis and on time treatment. Introduction of new biochemical markers as the early diagnosis of complications after coronary revascularization is very important in this p...
متن کاملPharmacological treatment of acute coronary syndromes.
Many trials have examined the efficacy of medications used in acute coronary syndromes. This paper reviews those now recommended in patients with unstable angina and non-ST-segment elevation myocardial infarction. There are currently seven groups of drugs that are used in the management of such patients.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Cardiology
سال: 2011
ISSN: 1949-8462
DOI: 10.4330/wjc.v3.i10.315